AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 280: H1318-H1323, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Leenen, F. H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Leenen, F. H. H.
Vol. 280, Issue 3, H1318-H1323, March 2001

AT1 receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline

Jing Zhang and Frans H. H. Leenen

Hypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7 Canada

Sympathetic hyperactivity and hypertension caused by chronic treatment with ouabain or sodium-rich artificial cerebrospinal fluid (aCSF) can be prevented by central administration of an angiotensin type 1 (AT1) receptor blocker. In the present study, we assessed whether, in Wistar rats, chronic peripheral treatment with the AT1 receptor blockers losartan and embusartan can exert sufficient central effects to prevent these central effects of ouabain and sodium. Losartan or embusartan (both at 100 mg · kg-1 · day-1) were given subcutaneously once daily. Ouabain (50 µg/day) was infused subcutaneously, and sodium-rich aCSF (1.2 M Na+, 5 µl/h) was infused intracerebroventricularly, both by osmotic minipump for 13-14 days. The mean arterial pressure (MAP) at rest and in response to air stress and intracerebroventricularly injection of guanabenz (75 µg/7.5 µl), ANG II (30 ng/3 µl), and ouabain (0.5 µg/2 µl) were then measured. In control rats, chronic treatment with ouabain subcutaneously and hypertonic saline intracerebroventricularly both increased baseline MAP by 20-25 mmHg and enhanced twofold the pressor responses to air stress and depressor responses to the alpha 2-adrenoceptor agonist guanabenz. Simultaneous treatment with losartan or embusartan fully prevented hypertension, maintained normal responses to air stress and guanabenz, and attenuated pressor responses to acute intracerebroventricular injection of ANG II and ouabain. We concluded that peripheral administration of losartan as well as embusartan can cause sufficient central effects to prevent the sympathetic hyperactivity and hypertension induced by chronic peripheral ouabain and central sodium.

brain renin-angiotensin system; losartan; embusartan; angiotensin II


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Briones, F. E. Xavier, S. M. Arribas, M. C. Gonzalez, L. V. Rossoni, M. J. Alonso, and M. Salaices
Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H193 - H201.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. V. Pitzalis, J. M. Hamlyn, E. Messaggio, M. Iacoviello, C. Forleo, R. Romito, E. de Tommasi, P. Rizzon, G. Bianchi, and P. Manunta
Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy
Eur J Heart Fail, March 1, 2006; 8(2): 179 - 186.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Chen, H. Chen, A. Hoffmann, D. R. Cool, D. I. Diz, M. C. Chappell, A. Chen, and M. Morris
Adenovirus-Mediated Small-Interference RNA for In Vivo Silencing of Angiotensin AT1a Receptors in Mouse Brain
Hypertension, February 1, 2006; 47(2): 230 - 237.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
Y. Chen, H. Chen, and M. Morris
Enhanced osmotic responsiveness in angiotensin AT1a receptor deficient mice: evidence for a role for AT1b receptors
Exp Physiol, September 1, 2005; 90(5): 739 - 746.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online